Trial Profile
A 6-Week Open Label Cross-Over Study With 2 Different Daily Doses of Minirin Oral Lyophilisate (120 microg and 240 microg) and 2 Different Daily Doses of Minirin Tablet (0.2 mg and 2 x 0.2 mg) in Children and Adolescents With Primary Nocturnal Enuresis (PNE).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 May 2011
Price :
$35
*
At a glance
- Drugs Desmopressin (Primary)
- Indications Enuresis
- Focus Therapeutic Use
- Acronyms PALAT
- Sponsors Ferring Pharmaceuticals
- 25 Feb 2009 New trial record